Status:
ENROLLING_BY_INVITATION
Transcranial Direct Current to Treat Epilepsy at Home
Lead Sponsor:
Stanford University
Conditions:
Epilepsies, Partial
Eligibility:
All Genders
18-100 years
Phase:
EARLY_PHASE1
Brief Summary
This is a placebo-controlled study of the effectiveness of transcranial direct current stimulation (tDCS) at home to reduce seizures and EEG spikes.
Detailed Description
Electrical stimulation is a promising new therapy to reduce seizures, but current methods require inserting wires under the skull or into brain. This project will use direct-current electrical stimula...
Eligibility Criteria
Inclusion
- Age 18-100, inclusive.
- Has a clinical diagnosis of epilepsy
- Has at least 4 countable seizures per month
- Has not had control with at least 2 anti-seizure medicines
- Able to maintain a constant medication for duration of the study (rescue meds allowed)
- Subject or legally authorized representative is able to understand consent and keep a seizure diary in English
Exclusion
- A disease likely to progress over course of the study
- Psychogenic non-epileptic seizures
- Suicide attempt or psychiatric hospitalization past 2 years
- A skin condition interfering with scalp electrodes or allergy to silver
- Women will verify not pregnant, and if applicable, have a serum pregnancy test
Key Trial Info
Start Date :
May 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04309812
Start Date
May 26 2021
End Date
December 30 2025
Last Update
November 27 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford Hospital
Stanford, California, United States, 94305-5235
2
Stanford University School of Medicine
Stanford, California, United States, 94305-5235